Pharmacologic Treatment of Peripheral Neuropathy

Article information

J Korean Med Assoc. 2004;47(10):1002-1008
Publication date (electronic) : 2004 October 30
doi : https://doi.org/10.5124/jkma.2004.47.10.1002
Department of Neurology, Ajou University College of Medicine & Hospital, Korea. isjoo@ajou.ac.kr

Abstract

Peripheral neuropathy is a common neurological disorder and has a variety of identifiable causes such as diabetes, metabolic derangements, neurotoxic substances, and even genetic abnormalities. Even with a thorough evaluation, however, the underlying cause cannot be identified in a large portion of peripheral neuropathy. In addition to the diagnostic dilemma, the wide spectrum of clinical manifestations with a variety of combinations of altered sensation, muscle weakness, and autonomic symptoms in peripheral neuropathy also makes it difficult to introduce an appropriate management. Treatments for peripheral neuropathy are categorized according to the underlying conditions and the strategies designed to relieve peripheral nerve pain irrespective of the cause. This article summarizes the mechanisms of peripheral neuropathic pain and current pharmacologic treatments including tricyclic antidepressants and anticonvulsants.

References

1. Martyn CN, Hughes RAC. Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry 1997. 62310–318.
2. Dyck PJ, Oviatt KF, Lambert EH. Intensive evaluation of referred unclassified neuropathies yields improved diagnosis. Ann Neurol 1981. 10222–226.
3. England JD, Asbury AK. Peripheral neuropathy. Lancet 2004. 3632151–2161.
4. Merskey H, Bogduk N, et al, eds. Classification of chronic pain 1994. 2nd edth ed. Seatle: IASP Press;
5. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999. 3531959–1964.
6. Wolf CJ. Dissecting out mechanisms responsible for peripheral neuropathic pain: Implications for diagnosis and therapy. Life Sci 2004. 742605–2610.
7. Orza F, Boswell MV, Rosenberg SK. Neuropathic pain: Review of mechanisms and pharmacologic management. Neuro Rehabilitation 2000. 1415–23.
8. Dworkin RH, Backonja M, Rowbotham MC, Allen RR, Argoff CR, Weinstein SM, et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol 2003. 601524–1534.
9. Sindrup SH, Jensen TS. Pharmacologic treatment of pain in polyneuropathy. Neurology 2000. 55915–920.
10. Backonja MM. Use of anticonvulsant for treatment of neuropathic pain. Neurology 2002. 59Suppl 2. S14–S17.

Article information Continued

Figure 1

CIDP : chronic inflammatory demyelinating polyneuropathy, GBS : Guillain-Barré syndrome

Figure 2

Table 1

Table 1

Table 2

Table 2